The recent departures of two key managing directors from Harvard Management Company (HMC) have sparked intrigue and raised questions about the future of the firm and its $56.9 billion endowment. Adam Goldstein and Elaine Chan, both integral to the lean operation built under N.P. 'Narv' Narvekar's leadership, have left their positions just weeks after Narvekar's plans to retire in the fall of 2027 were announced.
What makes this particularly fascinating is the timing of these departures. With Narvekar's retirement on the horizon, the firm is poised for its first CEO transition in nearly a decade. The fact that Goldstein and Chan have chosen to leave before Narvekar's official departure suggests a potential shift in the senior team dynamics and raises questions about the future direction of HMC.
The Impact of Departures
The absence of Goldstein and Chan leaves a notable gap in HMC's senior ranks. Both individuals played crucial roles in Narvekar's restructuring efforts, which saw a significant overhaul of Harvard's endowment management. Their departure could potentially impact the firm's ability to maintain the momentum gained under Narvekar's leadership.
One thing that immediately stands out is the potential impact on HMC's San Francisco office. Chan was expected to be a key presence in this new satellite location, which was established to expand Harvard's reach into West Coast technology and venture capital investments. With her departure, the future of this office and its strategic importance may be called into question.
Compensation and Career Paths
Goldstein's compensation as HMC's highest-paid managing director in 2024, earning nearly $3.5 million, highlights the financial incentives and rewards within the firm. His departure to become CFO of an AI infrastructure company suggests a shift in career focus and a potential desire for a different professional challenge.
Chan's career path, which includes investment roles at the Johnson Company and the Robert Wood Johnson Foundation, showcases a diverse background in private equity and portfolio management. Her decision to join HMC during a challenging period for the endowment and her subsequent departure after its significant growth under Narvekar's leadership, is an intriguing narrative.
Narvekar's Legacy and Endowment Growth
Under Narvekar's leadership, Harvard's endowment experienced remarkable growth, increasing by nearly 60% from $35.7 billion in 2016 to $56.9 billion in fiscal year 2025. This growth was accompanied by a significant shift in investment strategy, with private equity exposure increasing from 16% to over 40% of the endowment's portfolio.
Personally, I think Narvekar's legacy will be defined by his ability to turn around Harvard's endowment and his bold restructuring efforts. However, the question remains: Will his successor be able to maintain this momentum, especially with key managing directors already departing before the official transition?
Broader Implications and Future Trends
The departures of Goldstein and Chan highlight the fluid nature of leadership and the potential challenges in maintaining stability during periods of transition. As Harvard's endowment continues to evolve, especially with its increased focus on private equity, the firm's ability to attract and retain top talent will be crucial.
From my perspective, the next few years will be a critical period for HMC. The firm's ability to navigate the upcoming CEO transition, adapt to changing market conditions, and continue delivering strong investment returns will be a true test of its resilience and strategic vision.
